전체 메뉴 사이트맵

닫기

본문 바로가기

기술동향

홈 > BT정보 > 기술동향

scrap print facebook twitter me2day
글 읽기

The Year in Biotech

분류 기술동향 > 종합
출처 Technologyreview 조회 2542
자료발간일 2007-12-28 등록일 2007-12-31
내용바로가기 http://www.technologyreview.com/Biotech/19982/
평점 평점이 없습니다.

출처 : Technologyreview

 

The Year in Biotech

 

 

Genomics Gets Really Personal
This year may be remembered as the turning point for personal genomics, when broad gene testing for individuals finally came within reach. Two genomic pioneers–James Watson, codiscover of the structure of DNA, and Craig Venter, leader of the private effort to sequence the genome–published the sequence of their own genomes, revealing personal disease risks. (See “The $2 Million Genome” and “Craig Venter’s Genome.”)

 

Taking advantage of the explosion in human genomics data, several companies launched direct-to-consumer gene-testing services that analyze an individual’s genetic risk of contacting a range of diseases, including Alzheimer’s, diabetes, and cancer. (See “Your Future, on a Chip” and “Your Personal Genome.”) Critics say it’s not yet clear how useful such tests will be in preventing disease. So with price tags ranging from about $1,000, for a microarray analysis that analyzes a million genetic variations, to $350,000, for a full genome sequence, it might be worth waiting.

 


 

...................(계속)

 

☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.

☎ 해당 사이트 링크가 열리지 않을시 Bioin 담당자(042-879-8377, bioin@kribb.re.kr)에게로 연락주시기 바랍니다.

 

 

관련기사
New Year biotech IPO hopefuls gun for $369M 2018-01-03
Biotech VC scorecard: How the state's biggest firms fared in 201 2018-01-02
Biotech IPOs roared back in 2017, but what will the next year bring? 2017-12-26
Biotech IPOs roared back in 2017, but what will the next year bring? 2017-12-22
Biotech’s 2017 -back ‘set to continue next year’ 2017-12-22
CRISPR biotech Intellia promotes R&D head to CEO post 2017-12-19
Metabolic biotech Metacrine gains $22M for NASH tests 2017-12-11
UK Biotechs Present Novel Technologies at BioTrinity 2017 2017-12-04
What makes a modern-day biotech? 2017-11-29
Biotech veteran Julian Adams takes top job at Gamida Cell 2017-11-21